Treatment for overactive bladder

Der Urologe, 07/26/2011

This subgroup analysis of the CAP Study confirms the good efficacy and tolerability of solifenacin in male overactive bladder (OAB) in daily practice over a treatment period of 1 year.

Print Article Summary

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List